TY - JOUR
T1 - Inside minds, beneath diseases
T2 - Social cognition in amyotrophic lateral sclerosis-frontotemporal spectrum disorder
AU - Lillo, Patricia
AU - Caramelli, Paulo
AU - Musa, Gada
AU - Parrao, Teresa
AU - Hughes, Ricardo
AU - Aragon, Andres
AU - Valenzuela, Daniel
AU - Cea, Gabriel
AU - Aranguiz, Rafael
AU - Guimaraes, Henrique Cerqueira
AU - Rousseff, Laura
AU - Gambogi, Leandro Boson
AU - Mariano, Luciano Inacio
AU - Teixeira, Antonio Lucio
AU - Slachevsky, Andrea
AU - De Souza, Leonardo Cruz
N1 - Publisher Copyright:
©
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Objective To compare social cognition performance between patients with amyotrophic lateral sclerosis (ALS) and those patients with behavioural variant frontotemporal dementia (bvFTD). Methods We included 21 participants with ALS, 20 with bvFTD and 21 healthy controls who underwent a comprehensive cognitive battery, including the short version of the Social Cognition and Emotional Assessment (Mini-SEA), which comprises the faux pas test and Facial Emotion Recognition Test (FERT); Mini-Mental State Examination; Frontal Assessment Battery; lexical fluency (F-A-S), category fluency (animals/minute), digit span (direct and backwards) tests and the Hayling test. A post hoc analysis was conducted with the patients with ALS divided into two subgroups: patients without cognitive impairment (ALScn; n=13) and patients with cognitive impairment (ALSci; n=8). Results No significant difference was noted between participant groups in terms of the age, sex and education. ALS-total group and patients with bvFTD had similar disease durations. Patients with ALSci performed poorly when compared with controls with regard to the FERT (p<0.001), the faux pas (p<0.004) and the Mini-SEA (p<0.002) total scores. Moreover, patients with bvFTD performed poorly in comparison with controls in executive and social cognition tests. The performance of patients with ALSci was similar to that of patients with bvFTD, while the performance of patients with ALScn was similar to that of controls. Discussion Our findings support a cognitive continuum between ALS and bvFTD and shed light on the cognitive heterogeneity of ALS, expanding its possible neuropsychological profiles.
AB - Objective To compare social cognition performance between patients with amyotrophic lateral sclerosis (ALS) and those patients with behavioural variant frontotemporal dementia (bvFTD). Methods We included 21 participants with ALS, 20 with bvFTD and 21 healthy controls who underwent a comprehensive cognitive battery, including the short version of the Social Cognition and Emotional Assessment (Mini-SEA), which comprises the faux pas test and Facial Emotion Recognition Test (FERT); Mini-Mental State Examination; Frontal Assessment Battery; lexical fluency (F-A-S), category fluency (animals/minute), digit span (direct and backwards) tests and the Hayling test. A post hoc analysis was conducted with the patients with ALS divided into two subgroups: patients without cognitive impairment (ALScn; n=13) and patients with cognitive impairment (ALSci; n=8). Results No significant difference was noted between participant groups in terms of the age, sex and education. ALS-total group and patients with bvFTD had similar disease durations. Patients with ALSci performed poorly when compared with controls with regard to the FERT (p<0.001), the faux pas (p<0.004) and the Mini-SEA (p<0.002) total scores. Moreover, patients with bvFTD performed poorly in comparison with controls in executive and social cognition tests. The performance of patients with ALSci was similar to that of patients with bvFTD, while the performance of patients with ALScn was similar to that of controls. Discussion Our findings support a cognitive continuum between ALS and bvFTD and shed light on the cognitive heterogeneity of ALS, expanding its possible neuropsychological profiles.
KW - ALS
KW - cognition
KW - frontotemporal dementia
KW - motor neuron disease
UR - http://www.scopus.com/inward/record.url?scp=85096347710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096347710&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2020-324302
DO - 10.1136/jnnp-2020-324302
M3 - Article
C2 - 32962983
AN - SCOPUS:85096347710
SN - 0022-3050
VL - 91
SP - 1279
EP - 1282
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
IS - 12
ER -